
Strategic Intent: Understanding Crossover Strategies in Biotech With Sofinnova Partners’ David Evans
27.10.2026
0:00
30:17
In this episode of Strategic Intent, Partner at Sofinnova Partners, David Evans discusses his transition from Roche Venture Fund, different investments strategies, general market analysis across Europe and US, as well as growing therapeutics area trends within biotech.
Więcej odcinków z kanału "Citeline Podcasts"



Nie przegap odcinka z kanału “Citeline Podcasts”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








